News
DMRA
29.08
-0.31%
-0.09
Analysts’ Top Healthcare Picks: Vertex Pharmaceuticals (VRTX), Valneva (VALN)
TipRanks · 2d ago
Analysts Are Bullish on These Healthcare Stocks: Damora Therapeutics (DMRA), Summit Therapeutics (SMMT)
TipRanks · 2d ago
Danaher Posts Q2 Results, Joins Calix, Equifax And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
Benzinga · 3d ago
Damora Therapeutics Completes Cayman Islands Redomestication
TipRanks · 3d ago
Weekly Report: what happened at DMRA last week (0713-0717)?
Weekly Report · 4d ago
Damora Therapeutics completes redomestication to the Cayman Islands
TipRanks · 07/17 12:20
Damora Therapeutics redomiciles from Delaware to Cayman Islands
PUBT · 07/17 12:02
Damora Announces Redomestication from Delaware to Cayman Islands
Barchart · 07/17 07:00
Weekly Report: what happened at DMRA last week (0706-0710)?
Weekly Report · 07/13 09:26
Weekly Report: what happened at DMRA last week (0629-0703)?
Weekly Report · 07/06 09:28
DAMORA THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 07/01 20:01
RBC Capital Keeps Their Buy Rating on Damora Therapeutics (DMRA)
TipRanks · 06/30 11:05
Weekly Report: what happened at DMRA last week (0622-0626)?
Weekly Report · 06/29 09:26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Damora Therapeutics (DMRA), Summit Therapeutics (SMMT) and Elicio Therapeutics (ELTX)
TipRanks · 06/22 10:33
Weekly Report: what happened at DMRA last week (0615-0619)?
Weekly Report · 06/22 09:29
Damora Therapeutics Announces Results of 2026 Annual Meeting
TipRanks · 06/17 21:55
Damora Therapeutics shareholders elect Landsittel, Turtle to board
PUBT · 06/17 20:01
Wedbush Sticks to Their Buy Rating for Damora Therapeutics (DMRA)
TipRanks · 06/16 13:26
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Rhythm Pharmaceuticals (RYTM) and Damora Therapeutics (DMRA)
TipRanks · 06/15 11:01
Weekly Report: what happened at DMRA last week (0608-0612)?
Weekly Report · 06/15 09:29
More
Webull provides a variety of real-time DMRA stock news. You can receive the latest news about DAMORA THERAPEUT through multiple platforms. This information may help you make smarter investment decisions.
About DMRA
Damora Therapeutics Inc, formerly Galecto, Inc, is a clinical-stage biotechnology company focused on the development of novel treatments for cancer and liver diseases. The Company is engaged in the advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is significant medical need for disease-modifying treatments. It offers a multiple programs including asset, DMR-001, an investigational monoclonal antibody therapy targeting mutCALR. DMR-001 was designed to exclusively bind to mutCALR with exquisite selectivity, potency, and extended half-life, with potential to enable convenient, infrequent subcutaneous dosing.